Other Species / Isoforms
  PKCE (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S24-p
SLKPTAWsLRHAVGP
0 1
PKCE (human) SLKPTAWSLRHAVGP S24
PKCE (mouse) SLKPTAWsLRHAVGP S24-p
PKCE (rat) SLKPTAWSLRHAVGP S24
S62-p
ATKQKTNsPAWHDEF
0 1
PKCE (human) ATKQKTNSPAWHDEF S62
PKCE (mouse) ATKQKTNsPAWHDEF S62-p
PKCE (rat) ATKQKTNSPAWHDEF S62
S132
VYVIIDLSGSSGEAP
0 1
PKCE (human) VYVIIDLSGSSGEAP S132
PKCE (mouse) VYVIIDLSGSSGEAP S132
PKCE (rat) VYVIIDLsGssGEAP S132-gl
S134
VIIDLSGSSGEAPKD
0 1
PKCE (human) VIIDLSGSSGEAPKD S134
PKCE (mouse) VIIDLSGSSGEAPKD S134
PKCE (rat) VIIDLsGssGEAPKD S134-gl
S135
IIDLSGSSGEAPKDN
0 1
PKCE (human) IIDLSGSSGEAPKDN S135
PKCE (mouse) IIDLSGSSGEAPKDN S135
PKCE (rat) IIDLsGssGEAPKDN S135-gl
T175
NGHKFMATYLRQPTY
0 1
PKCE (human) NGHKFMATYLRQPtY T175
PKCE (mouse) NGHKFMATYLRQPTY T175
PKCE (rat) NGHKFMAtyLRQPTY T175-p
Y176
GHKFMATYLRQPTYC
0 1
PKCE (human) GHKFMATYLRQPtYC Y176
PKCE (mouse) GHKFMATYLRQPTYC Y176
PKCE (rat) GHKFMAtyLRQPTYC Y176-p
T181
ATYLRQPTYCSHCRD
0 3
PKCE (human) ATYLRQPtYCSHCRD T181-p
PKCE (mouse) ATYLRQPTYCSHCRD T181
PKCE (rat) AtyLRQPTYCSHCRD T181
T228-p
AGLKKQEtPDEVGsQ
0 3
PKCE (human) AGLKKQEtPDQVGsQ T228-p
PKCE (mouse) AGLKKQEtPDEVGsQ T228-p
PKCE (rat) AGLKKQETPDEVGSQ T228
S234-p
EtPDEVGsQRFSVNM
Upstream
1 2
Treatment
  • 1Na-PP1
  • bisindolylmaleimide
  • Go_6976
  • PDGF
  • phorbol_ester
PKCE (human) EtPDQVGsQRFSVNM S234-p
PKCE (mouse) EtPDEVGsQRFSVNM S234-p
PKCE (rat) ETPDEVGSQRFSVNM S234
Y250
HKFGIHNYKVPTFCD
0 5
PKCE (human) HKFGIHNYKVPTFCD Y250
PKCE (mouse) HKFGIHNYKVPTFCD Y250
PKCE (rat) HKFGIHNyKVPTFCD Y250-p
S261
TFCDHCGSLLWGLLR
0 1
PKCE (human) TFCDHCGsLLWGLLR S261-p
PKCE (mouse) TFCDHCGSLLWGLLR S261
PKCE (rat) TFCDHCGSLLWGLLR S261
T286
NVHRRCETNVAPNCG
1 0
PKCE (human) NVHRRCETNVAPNCG T286
PKCE (mouse) NVHRRCETNVAPNCG T286
PKCE (rat) NVHRRCEtNVAPNCG T286-gl
T286
NVHRRCETNVAPNCG
0 1
PKCE (human) NVHRRCEtNVAPNCG T286-p
PKCE (mouse) NVHRRCETNVAPNCG T286
PKCE (rat) NVHRRCETNVAPNCG T286
T309-p
VLADLGVtPDkITNs
0 8
PKCE (human) VLADLGVtPDKITNs T309-p
PKCE (mouse) VLADLGVtPDkITNs T309-p
PKCE (rat) VLADLGVTPDKITNS T309
K312-ub
DLGVtPDkITNsGQR
0 1
PKCE (human) DLGVtPDKITNsGQR K312
PKCE (mouse) DLGVtPDkITNsGQR K312-ub
PKCE (rat) DLGVTPDKITNSGQR K312
S316-p
tPDkITNsGQRRKKL
Upstream
1 3
Treatment
  • 1Na-PP1
  • bisindolylmaleimide
  • Go_6976
  • PDGF
  • phorbol_ester
PKCE (human) tPDKITNsGQRRkKL S316-p
PKCE (mouse) tPDkITNsGQRRKKL S316-p
PKCE (rat) TPDKITNSGQRRKKL S316
K321
TNsGQRRKKLAAGAE
1 0
PKCE (human) TNsGQRRkKLIAGAE K321-ub
PKCE (mouse) TNsGQRRKKLAAGAE K321
PKCE (rat) TNSGQRRKKLAAGAE K321
S329-p
KLAAGAEsPQPAsGN
0 13
PKCE (human) KLIAGAEsPQPAsGS S329-p
PKCE (mouse) KLAAGAEsPQPAsGN S329-p
PKCE (rat) KLAAGAEsPQPASGN S329-p
S334-p
AEsPQPAsGNsPSED
0 2
PKCE (human) AEsPQPAsGSsPsEE S334-p
PKCE (mouse) AEsPQPAsGNsPSED S334-p
PKCE (rat) AEsPQPASGNsPSED S334
S337-p
PQPAsGNsPSEDDRs
0 11
PKCE (human) PQPAsGSsPsEEDRs S337-p
PKCE (mouse) PQPAsGNsPSEDDRs S337-p
PKCE (rat) PQPASGNsPSEDDRS S337-p
S339
PAsGNsPSEDDRsKs
0 1
PKCE (human) PAsGSsPsEEDRsKs S339-p
PKCE (mouse) PAsGNsPSEDDRsKs S339
PKCE (rat) PASGNsPSEDDRSKs S339
S344-p
sPSEDDRsKsAPtsP
0 3
PKCE (human) sPsEEDRsKsAPTsP S344-p
PKCE (mouse) sPSEDDRsKsAPtsP S344-p
PKCE (rat) sPSEDDRSKsAPtsP S344
S346-p
SEDDRsKsAPtsPCD
Downstream
2 11
Effects on Biological Processes:
  • cell cycle regulation
PKCE (human) sEEDRsKsAPTsPCD S346-p
PKCE (mouse) SEDDRsKsAPtsPCD S346-p
PKCE (rat) SEDDRSKsAPtsPCD S346-p
S346
SEDDRsKSAPtsPCD
0 1
PKCE (human) sEEDRsKSAPTsPCD S346
PKCE (mouse) SEDDRsKSAPtsPCD S346
PKCE (rat) SEDDRSKsAPtsPCD S346-gl
T349-p
DRsKsAPtsPCDQEL
0 4
PKCE (human) DRsKsAPTsPCDQEI T349
PKCE (mouse) DRsKsAPtsPCDQEL T349-p
PKCE (rat) DRSKsAPTsPCDQEL T349
T349
DRsKsAPTsPCDQEL
0 1
PKCE (human) DRsKsAPTsPCDQEI T349
PKCE (mouse) DRsKsAPTsPCDQEL T349
PKCE (rat) DRSKsAPtsPCDQEL T349-gl
S350-p
RsKsAPtsPCDQELK
Upstream
Downstream
1 10
Effects on Biological Processes:
  • cell cycle regulation
Treatment
  • insulin
PKCE (human) RsKsAPTsPCDQEIK S350-p
PKCE (mouse) RsKsAPtsPCDQELK S350-p
PKCE (rat) RSKsAPtSPCDQELK S350
S350
RsKsAPtSPCDQELK
0 1
PKCE (human) RsKsAPTSPCDQEIK S350
PKCE (mouse) RsKsAPtSPCDQELK S350
PKCE (rat) RSKsAPtsPCDQELK S350-gl
S368-p
NNIRKALsFDNRGEE
Upstream
Downstream
3 17
Effects on Modified Protein
  • molecular association, regulation
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • 1Na-PP1
  • ATP
  • bisindolylmaleimide
  • Go_6976
  • Go_6983
  • PDGF
  • phorbol_ester
  • siRNA
PKCE (human) NNIRKALsFDNRGEE S368-p
PKCE (mouse) NNIRKALsFDNRGEE S368-p
PKCE (rat) NNIRKALsFDNRGEE S368-p
S368
NNIRKALSFDNRGEE
1 0
PKCE (human) NNIRKALSFDNRGEE S368
PKCE (mouse) NNIRKALSFDNRGEE S368
PKCE (rat) NNIRKALsFDNRGEE S368-gl
S380
GEEHRASSAtDGQLA
1 0
PKCE (human) GEEHRAASsPDGQLM S380
PKCE (mouse) GEEHRASSAtDGQLA S380
PKCE (rat) GEEHRASsSTDGQLA S380-p
A381
EEHRASSAtDGQLAs
0 1
PKCE (human) EEHRAASsPDGQLMs S381-p
PKCE (mouse) EEHRASSAtDGQLAs A381
PKCE (rat) EEHRASsSTDGQLAs S381
T382-p
EHRASSAtDGQLAsP
0 2
PKCE (human) EHRAASsPDGQLMsP P382
PKCE (mouse) EHRASSAtDGQLAsP T382-p
PKCE (rat) EHRASsSTDGQLAsP T382
S388-p
AtDGQLAsPGENGEV
0 11
PKCE (human) sPDGQLMsPGENGEV S388-p
PKCE (mouse) AtDGQLAsPGENGEV S388-p
PKCE (rat) STDGQLAsPGENGEV S388-p
S418
IKVLGKGSFGKVMLA
1 0
PKCE (human) IKVLGKGSFGkVMLA S418
PKCE (mouse) IKVLGKGSFGKVMLA S418
PKCE (rat) IKVLGKGsFGKVMLA S418-gl
K421
LGKGSFGKVMLAELK
0 1
PKCE (human) LGKGSFGkVMLAELK K421-ac
PKCE (mouse) LGKGSFGKVMLAELK K421
PKCE (rat) LGKGsFGKVMLAELK K421
K430
MLAELKGKDEVYAVK
0 1
PKCE (human) MLAELKGkDEVyAVK K430-ac
PKCE (mouse) MLAELKGKDEVYAVK K430
PKCE (rat) MLAELKGKDEVYAVK K430
Y434
LKGKDEVYAVKVLKK
0 2
PKCE (human) LKGkDEVyAVKVLKK Y434-p
PKCE (mouse) LKGKDEVYAVKVLKK Y434
PKCE (rat) LKGKDEVYAVKVLKK Y434
T453
QDDDVDCTMTEKRIL
1 0
PKCE (human) QDDDVDCTMTEKRIL T453
PKCE (mouse) QDDDVDCTMTEKRIL T453
PKCE (rat) QDDDVDCtMTEKRIL T453-gl
Y488
RLFFVMEYVNGGDLM
1 0
PKCE (human) RLFFVMEYVNGGDLM Y488
PKCE (mouse) RLFFVMEYVNGGDLM Y488
PKCE (rat) RLFFVMEyVNGGDLM Y488-p
T517
RFYAAEVTSALMFLH
1 0
PKCE (human) RFYAAEVTSALMFLH T517
PKCE (mouse) RFYAAEVTSALMFLH T517
PKCE (rat) GFYAAEVtSALMFLH T517-gl
K534
GVIYRDLKLDNILLD
1 0
PKCE (human) GVIYRDLkLDNILLD K534-sm
PKCE (mouse) GVIYRDLKLDNILLD K534
PKCE (rat) GVIYRDLKLDNILLD K534
T566-p
MNGVTTTtFCGTPDY
Upstream
Downstream
6 2
PKCE (human)
T566-p
PKCE (mouse)
T566-p
PKCE (rat)
T566-p
Effects on Modified Protein
  • enzymatic activity, induced
Phosphatases, in vitro:
  • PPP2CB (human)
Treatment
  • calyculin_A
  • collagen_IV
  • fibronectin
PKCE (human) LNGVTTTtFCGTPDy T566-p
PKCE (mouse) MNGVTTTtFCGTPDY T566-p
PKCE (rat) LNGVTTTTFCGTPDY T566
Y573
tFCGTPDYIAPEILQ
1 0
PKCE (human) tFCGTPDyIAPEILQ Y573-p
PKCE (mouse) tFCGTPDYIAPEILQ Y573
PKCE (rat) TFCGTPDYIAPEILQ Y573
S636
WLSKEAVSILKAFMT
0 1
PKCE (human) WLSKEAVSILKAFMT S636
PKCE (mouse) WLSKEAVSILKAFMT S636
PKCE (rat) WLSKEAVsILKAFMt S636-p
T643
SILKAFMTKNPHKRL
0 1
PKCE (human) SILKAFMTKNPHKRL T643
PKCE (mouse) SILKAFMTKNPHKRL T643
PKCE (rat) sILKAFMtKNPHKRL T643-p
K679
DWVLLEQKKIKPPFK
0 1
PKCE (human) DWVLLEQkKIKPPFK K679-ub
PKCE (mouse) DWVLLEQKKIKPPFK K679
PKCE (rat) DWVLLEQKKMKPPFK K679
T703-p
NNFDQDFtREEPILt
1 3
PKCE (human) NNFDQDFTREEPVLt T703
PKCE (mouse) NNFDQDFtREEPILt T703-p
PKCE (rat) NNFDQDFtREEPILt T703-p
T710-p
tREEPILtLVDEAII
Upstream
Downstream
3 57
Effects on Modified Protein
  • enzymatic activity, induced
Phosphatases, in vitro:
  • PPP2CB (human)
Treatment
  • collagen_IV
  • fibronectin
  • long-term_potentiation
PKCE (human) TREEPVLtLVDEAIV T710-p
PKCE (mouse) tREEPILtLVDEAII T710-p
PKCE (rat) tREEPILtLVDEAIV T710-p
T710
tREEPILTLVDEAII
1 0
PKCE (human) TREEPVLTLVDEAIV T710
PKCE (mouse) tREEPILTLVDEAII T710
PKCE (rat) tREEPILtLVDEAIV T710-gl
S729-p
QEEFKGFsyFGEDLM
Upstream
Downstream
17 24
PKCE (human)
S729-p
PKCE (mouse)
S729-p
PKCE (rat)
S729-p
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
Phosphatases, in vitro:
  • PPP2CB (human)
Regulatory protein:
  • LPIN1 (mouse)
  • PKCD (mouse)
  • TORC2 (mouse)
Treatment
  • ascomycin
  • calyculin_A
  • cell_adhesion
  • chelerythrine
  • ciclosporin
  • collagen_IV
  • cytochalasin_D
  • fibronectin
  • high_cell_density
  • insulin
  • LLnL
  • LY294002
  • nocodazole
  • okadaic_acid
  • PA
  • PD98059
  • peptide inhibitor
  • phorbol_ester
  • rapamycin
  • Ro31-8220
  • serum
  • serum_starvation
  • siRNA
  • wortmannin
PKCE (human) QEEFKGFsYFGEDLM S729-p
PKCE (mouse) QEEFKGFsyFGEDLM S729-p
PKCE (rat) QEEFKGFsYFGEDLM S729-p
Y730-p
EEFKGFsyFGEDLMP
0 3
PKCE (human) EEFKGFsYFGEDLMP Y730
PKCE (mouse) EEFKGFsyFGEDLMP Y730-p
PKCE (rat) EEFKGFsYFGEDLMP Y730